January 22, 2008 - The International Board of Heart Rhythm Examiners (IBHRE) issued the first standardized cardiac pacing exam for Japanese allied professionals, which marks the first time the IBHRE exam, designed to test professional competency in cardiac pacing, defibrillation and electrophysiology, will be tailored to the needs of a global health care system outside of the U.S.

January 22, 2008 - GE Healthcare was rated first in Overall Service Performance among vendors for PET and PET/CT service, marking the company’s second consecutive year achieving the award, according to IMV ServiceTrak, an independent third-party research firm.

January 22, 2008 - The FDA cleared St. Jude Medical's EnSite Fusion Registration Module, software designed to help physicians create detailed heart models to facilitate the diagnosis and delivery of therapy for complex abnormal atrial heart rhythms, including Atrial Fibrillation (AF), for use with minimally invasive electrophysiology procedures.

January 22, 2008 – The FDA cleared a fully automated ablation system supporting an open-loop irrigated catheter using remote navigation with the Niobe Magnetic Navigation System, designed by Stereotaxis and the CARTO RMT System by Biosense Webster to improve control and versatility when performing ablations.

January 22, 2008 - A new stent with a nanothin surface application known as Polyzene-F shows promise in opening and healing blocked heart arteries reportedly without the potential risks of thrombosis posed by drug-eluting stents, according to a study being presented at the 20th annual International Symposium on Endovascular Therapy (ISET).

January 22, 2008 - Boston Scientific Corp. today announced CE Mark approval for its COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter defibrillator (ICD), representing entirely new platforms to treat heart failure and sudden cardiac death.

January 22, 2008 � Blocked abdomen and leg arteries, known as peripheral arterial disease (PAD), is more costly to treat than coronary heart diseases (CAD), according to research being presented at the 20th annual International Symposium on Endovascular Therapy (ISET).

Both CAD and PAD are atherosclerotic cardiovascular diseases involving blocked arteries, and are treated with the same methods, including medication, minimally invasive (endovascular) techniques � such as balloon angioplasty and stenting � or surgery, depending on the location and severity of the disease.

January 22, 2008 - A new stent with a nanothin surface application shows promise in opening and healing blocked heart arteries without the life-threatening dangers of thrombosis and heart attack associated with drug-eluting stents, according to a study being presented at the 20th annual International Symposium on Endovascular Therapy (ISET).

January 21, 2008 - Boston Scientific Corp. announced a third software enhancement to its iLab Ultrasound Imaging System, the iLab System 1.3, which is designed to strengthen physician confidence in the diagnosis and intervention of percutaneous coronary intervention (PCI) and increase workflow efficiency.

January 21, 2008 – The FDA cleared St. Jude Medical Inc.’s EnSite Fusion Registration Module, a software designed to help physicians create detailed heart models to facilitate the diagnosis and delivery of therapy for complex abnormal atrial heart rhythms, including Atrial Fibrillation (AF).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now